Back

Outcomes in patients with renal impairment and myocardial injury or infarction identified by high-sensitivity cardiac troponin testing: a secondary analysis of the High-STEACS trial

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Kidney disease and the heart Renal Failure and Cardiovascular Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Peter Gallacher

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Incidence, etiologies and predictors of 30-day readmission after percutaneous coronary intervention in end-stage renal disease patients; Analysis from national readmission database
Professor A. Amanullah (Philadelphia, US)
Abstract Slides
Presentation thumbnail
Impact of Renal Dysfunction on Real-world Outcome of the ESC 0/1-hour Algorithm
Professor R. Twerenbold (Hamburg, DE)
Abstract
Presentation thumbnail
Left atrial volume index predicts improvement in renal function after catheter ablation of atrial fibrillation
Doctor K. Usuda (Cambridge, US)
Abstract
Presentation thumbnail
Early blood pressure reduction by intravenous vasodilators associates with acute kidney injury in patients with hypertensive acute decompensated heart failure
Doctor Y. arao (Ogaki, JP)
Abstract Slides
Presentation thumbnail
Prognostic value of C-reactive protein / albumin ratio for cardiovascular morbidity and mortality in end-stage renal disease patients with incident haemodialysis therapy
Assistant Professor H. Takahashi (Toyoake, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Kidney disease and the heart

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources